These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Is beta 2-microglobulin a marker of bone remodeling in Paget's disease of bone?]. Wilczek H. Cas Lek Cesk; 1997 Dec 03; 136(23):730-2. PubMed ID: 9476376 [Abstract] [Full Text] [Related]
7. Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity. Alvarez L, Peris P, Pons F, Guañabens N, Herranz R, Monegal A, Bedini JL, Deulofeu R, Martínez de Osaba MJ, Muñoz-Gómez J, Ballesta AM. Arthritis Rheum; 1997 Mar 03; 40(3):461-8. PubMed ID: 9082934 [Abstract] [Full Text] [Related]
8. Bone alkaline phosphatase in Paget's disease. Deftos LJ, Wolfert RL, Hill CS. Horm Metab Res; 1991 Nov 03; 23(11):559-61. PubMed ID: 1816067 [Abstract] [Full Text] [Related]
10. Low serum magnesium concentration in Paget's disease of bone (osteitis deformans). Taylor WH. Ann Clin Biochem; 1985 Nov 03; 22 ( Pt 6)():591-5. PubMed ID: 4073791 [Abstract] [Full Text] [Related]
11. New evidence that serum beta(2)-microglobulin behaves as a biological marker of bone remodelling in women. Ripoll E, Revilla M, Hernández ER, Arribas I, Villa LF, Rico H. Eur J Clin Invest; 1996 Aug 03; 26(8):681-5. PubMed ID: 8872064 [Abstract] [Full Text] [Related]
12. An evaluation of serum osteocalcin in Paget's disease of bone and its response to diphosphonate treatment. Coulton LA, Preston CJ, Couch M, Kanis JA. Arthritis Rheum; 1988 Sep 03; 31(9):1142-7. PubMed ID: 3048274 [Abstract] [Full Text] [Related]
13. Alterations in vitamin D metabolites during treatment of Paget's disease of bone with calcitonin or etidronate. Devlin RD, Gutteridge DH, Prince RL, Retallack RW, Worth GK. J Bone Miner Res; 1990 Nov 03; 5(11):1121-6. PubMed ID: 2125401 [Abstract] [Full Text] [Related]
14. Serum osteocalcin concentrations in Paget's disease of bone. Wilkinson MR, Wagstaffe C, Delbridge L, Wiseman J, Posen S. Arch Intern Med; 1986 Feb 03; 146(2):268-71. PubMed ID: 3484940 [Abstract] [Full Text] [Related]
15. Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget's disease. Meier C, Meinhardt U, Greenfield JR, De Winter J, Nguyen TV, Dunstan CR, Seibel MJ. Clin Lab; 2006 Feb 03; 52(1-2):1-10. PubMed ID: 16506358 [Abstract] [Full Text] [Related]
16. Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates. Alvarez L, Peris P, Guañabens N, Vidal S, Ros I, Pons F, Filella X, Monegal A, Muñoz-Gomez J, Ballesta AM. Arthritis Rheum; 2003 Mar 03; 48(3):824-8. PubMed ID: 12632438 [Abstract] [Full Text] [Related]
17. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. Garnero P, Delmas PD. J Clin Endocrinol Metab; 1993 Oct 03; 77(4):1046-53. PubMed ID: 8104954 [Abstract] [Full Text] [Related]
18. Serum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of bone. Delmas PD, Demiaux B, Malaval L, Chapuy MC, Meunier PJ. Calcif Tissue Int; 1986 Jan 03; 38(1):60-1. PubMed ID: 3079654 [Abstract] [Full Text] [Related]
19. Differential response of serum alkaline phosphatase and serum osteocalcin in Paget's osteosarcoma. Davie MW, Worsfold M, Sharp CA. Ann Clin Biochem; 1991 Mar 03; 28 ( Pt 2)():194-5. PubMed ID: 1859160 [Abstract] [Full Text] [Related]
20. Serum levels of pyridinium crosslinks in postmenopausal women and in Paget's disease of bone. Sinigaglia L, Varenna M, Binelli L, Beltrametti P, Zucchi F, Arrigoni M, Frignani S, Abbiati G. Calcif Tissue Int; 1997 Oct 03; 61(4):279-84. PubMed ID: 9312197 [Abstract] [Full Text] [Related] Page: [Next] [New Search]